Latest News
While scientists are optimistic about the research, federal funding for it is being threatened. Sen. Richard Blumenthal (D-Conn.) toured the Yale lab on Wednesday and said that hundreds of millions of dollars are at risk.
- May 31, 2024
The program will advance innovative research, and help facilitate the sharing of ideas, data, and knowledge to drive biomedical progress, therapeutics, and cures focused on combatting Alzheimer’s disease and related dementias.
- March 12, 2024
The newly announced election brings the number of AAP members from Yale to 53.
- August 26, 2022Source: YaleNews
What makes the human brain distinct from that of all other animals — including even our closest primate relatives? In an analysis of cell types in the prefrontal cortex of four primate species, Yale researchers identified species-specific — particularly human-specific — features, they report Aug. 25 in the journal Science.
- June 28, 2022
Damage to nerves of the brain and spinal cord is particularly devastating because these nerves do not grow back on their own. Perhaps, suggests a Yale-led study, they could regrow with a little help from science.
- June 01, 2022Source: YaleNews
An experimental drug restored brain synapses in two mouse models of Alzheimer’s disease, raising hopes that it could help revive cognitive function in human dementia patients.
- April 11, 2022
Can we predict who will develop Alzheimer’s disease and other dementias? Can we identify biomarkers to predict disease development early? What are the most promising treatment targets?
- February 17, 2022
Stephen Strittmatter, MD, PhD, will assume the position of chair of the Department of Neuroscience and director of the Kavli Institute for Neuroscience, effective March 1, 2022.
- December 21, 2021
LaShae Nicholson, PhD, from the laboratory of Stephen Strittmatter, and Rafael Perez, PhD, from the laboratory of Marina Picciotto, have been selected to receive the Kavli Postdoctoral Award for Academic Diversity.
- September 10, 2021
Strittmatter succeeds Pietro De Camilli, MD, who elected not to seek a new term after six years as chair. Jessica Cardin, PhD, becomes interim vice chair, succeeding Sreeganga Chandra, PhD.